PGE2 receptor (EP4) agonists: Potent dilators of human bronchi and future asthma therapy?

This publication has 17 references indexed in Scilit:

• EP4 receptor as a new target for bronchodilator therapy
  Thorax, 2011
• Heart Failure and Chronic Obstructive Pulmonary Disease
  JACC, 2011
• Differential reactivity of human mammary artery and saphenous vein to prostaglandin E₂: Implication for cardiovascular grafts
  British Journal of Pharmacology, 2011
• Vasorelaxation induced by prostaglandin E₂in human pulmonary vein: role of the EP₄receptor subtype
  British Journal of Pharmacology, 2008
• GW627368X ((N‐{2‐[4‐(4,9‐diethoxy‐1‐oxo‐1,3‐dihydro‐2H‐benzo[f]isoindol‐2‐yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP₄ receptor antagonist
  British Journal of Pharmacology, 2006
• EP₄ prostanoid receptor‐mediated vasodilatation of human middle cerebral arteries
  British Journal of Pharmacology, 2004
• The Role of Prostaglandin E Receptor Subtypes (EP1, EP2, EP3, and EP4) in Bone Resorption: An Analysis Using Specific Agonists for the Respective EPs
  Endocrinology, 2000
• Prostanoid receptors involved in the relaxation of human bronchial preparations
  British Journal of Pharmacology, 1999
• AH13205, A Selective Prostanoid EP₂‐receptor Agonist
  Cardiovascular Drug Reviews, 1993
• Characterization of prostanoid relaxant/inhibitory receptors (ψ) using a highly selective agonist, TR4979
  British Journal of Pharmacology, 1986